search
Back to results

Magnesium Sulfate as an Adjuvant to Caudal Bupivacaine in Lower Abdominal Surgeries in Paediatrics.

Primary Purpose

Pain, Postoperative

Status
Unknown status
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Magnesium SO4
Sponsored by
Cairo University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Pain, Postoperative focused on measuring postoperative pain , pediatrics , magnesium sulfate

Eligibility Criteria

1 Year - 7 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • age between 1 and 7 years, ASA(American Society of Anesthesiologists) physical status class |- || , patients scheduled for lower abdominal surgeries.

Exclusion Criteria:

  • patients with psychiatric disorders , children with cardiovascular,respiratory ,hepatic or renal dysfunction , known contraindications to regional anesthesia, ASA class |||- |V, hypersensitivity to magnesium or regular analgesic drugs.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm 3

    Arm Type

    Experimental

    Active Comparator

    Placebo Comparator

    Arm Label

    Intravenous magnesium group (Group IV)

    Caudal magnesium group (Group CA)

    Placebo group (Group P)

    Arm Description

    Group IV (n=30) will receive intravenous (IV) 20 ml magnesium SO4 (50 mg/ kg 10% MgSO4(magnesium sulphate) diluted in normal saline to a total volume of 20 ml(milliliter) ) and caudal anaesthesia using (bupivacaine 0.25% diluted in normal saline with total volume of 1 mL/kg) .

    Group CA (n=30) will receive IV 20 ml normal saline and caudal anaesthesia using (bupivacaine 0.25% and 50 mg Magnesium SO4 diluted in normal saline with total volume of 1mL/kg).

    Group P (n=30) ) will receive IV 20 ml normal saline and caudal anaesthesia using (bupivacaine 0.25% diluted in normal saline with total volume of 1 mL/kg).

    Outcomes

    Primary Outcome Measures

    The analgesic effect of intravenous magnesium in children undergoing lower abdominal surgeries
    Post operative pain score will be assessed using children's Hospital of Eastern Ontario Pain scale which is based on 6 criteria: Crying Facial expression Child verbal expression Torso (body position) Touching or grabbing at wound Legs position Criterion 1 is given a score of 1-3, criterion 2 and 3 are given a score of 0-2 while criterion 4, 5 and 6 are given a score of 1-2; making the worst possible score 13 while the least possible score is 4. A total score ≤ than 8 indicate adequate analgesia.

    Secondary Outcome Measures

    Time to first rescue analgesia
    Post operative first rescue analgesia time
    Post operative sedation score
    Sedation will be monitored after PACU arrival using Ramsay score : 1=fully awake , 2=drowsy but awakens spontaneously , 3=asleep but arouses and responds appropriately to simple verbal commands , 4=asleep,unresponsive to commands,but arouses to shoulder tap or loud verbal stimulus , 5=asleep and only responds to firm

    Full Information

    First Posted
    October 24, 2017
    Last Updated
    November 3, 2017
    Sponsor
    Cairo University
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT03322878
    Brief Title
    Magnesium Sulfate as an Adjuvant to Caudal Bupivacaine in Lower Abdominal Surgeries in Paediatrics.
    Official Title
    Intravenous Versus Caudal Magnesium Sulfate as an Adjuvant to Caudal Bupivacaine in Lower Abdominal Surgeries in Paediatrics Under General Anaesthesia
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    November 2017
    Overall Recruitment Status
    Unknown status
    Study Start Date
    November 2017 (Anticipated)
    Primary Completion Date
    December 2017 (Anticipated)
    Study Completion Date
    December 2017 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Cairo University

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Intravenous magnesium has been studied in pediatrics to reduce agitation after sevoflurane anesthesia in children undergoing adenotonsillectomy, reduce intraoperative rocuronium requirements, prevent laryngospasm and coughing after removal of the endotracheal tube in patients undergoing adenotonsillectomy. The aim of this study is to investigate the role of intravenous magnesium sulfate on postoperative pain management in paediatrics and to compare it with its effect when administered caudally in children undergoing lower abdominal surgeries.
    Detailed Description
    Postoperative pain in children is difficult to assess and is associated with strong emotional component . Recently, there is an increasing interest to study magnesium analgesic effects. Magnesium, the fourth most common cation in the body, inhibits calcium entry into the cell via a noncompetitive blockade of the N-methyl-d-aspartate (NMDA) receptors. Magnesium and the NMDA receptors are thought to be involved in the modulation of pain. Magnesium is also a physiological calcium antagonist at different voltage-gated channels, which may be important in the mechanisms of antinociception. As a NMDA antagonist, magnesium prevents the central sensitization from nociceptive stimulation. Many studies suggested that epidurally administered magnesium as an adjuvant could reduce the postoperative pain in adults. But few studies are available about the use of magnesium as an adjuvant in caudal block for postoperative analgesia in pediatrics. The aim of this study is to investigate the role of intravenous magnesium sulfate on postoperative pain management in paediatrics and to compare it with its effect when administered caudally in children undergoing lower abdominal surgeries. Objectives To determine the analgesic effect of intravenous magnesium in children undergoing lower abdominal surgeries. To evaluate and compare the efficacy of magnesium sulfate when administered intravenously versus caudally. To evaluate the sedative effect of intravenous magnesium in paediatrics. To illustrate the role of hypomagnesemia in post-operative pain. Population of study & disease condition Paediatric patients undergoing lower abdominal surgeries. Methodology in details Patients fulfilling the study inclusion criteria will be recruited and enrolled in the study after Ethical Committee approval. All parents will sign an informed consent to participate in the study after detailed explanation of the expected benefits and possible risks. Study groups This study will be performed in Cairo University specialized pediatric Hospital after approval of the Research Ethical Committee, and written informed consents from the parents. 90 participants will be randomly assigned using an online randomization program (http://www.randomizer.org) and the sealed envelop method into three groups: Intravenous magnesium group (Group IV) Caudal magnesium group (Group CA) Placebo group (Group P). Preoperative assessment: History taking, clinical examination and routine laboratory investigations will be checked for all patients to exclude any of the above mentioned exclusion criteria. Intraoperative management: After arrival of the patient to the operating theater 5 leads electrocardiography (ECG), automated non-invasive blood pressure monitoring (NIBP) and a pulse oximetry will be applied. Anaesthesia will be induced by inhalation of 6- 8 % sevoflurane , by an anesthetist blinded to the group allocation. Once consciousness is lost , intravenous access will be established, fentanyl (1- 2 μg/kg ) and atracurium (0.5 mg/ kg) will be given to facilitate tracheal intubation. Anaesthesia will be maintained by 1.2 % isoflurane, atracurium top up doses under controlled ventilation. The intravenous solutions (magnesium 10% for group IV or saline 0.9% for group CA and P) will be started then caudal block will be performed by the same anesthetist. For caudal puncture a 5 cm short beveled 22 G caudal needle will be used in the lateral decubitus position. After identifying the space using the loss of resistance technique with saline, the study solutions will be injected slowly with repetitive intermittent aspiration. Rescue analgesia in the form of fentanyl 1 μg/kg will be administered if haemodynamic parameters (blood pressure and heart rate) increased 20 % from the baseline. Surgery will be allowed to begin 10 min after performing the block. After emergence from anaesthesia, patients will be managed by an observer blinded to group allocation in the post anaesthesia care unit (PACU). Postoperative rescue analgesia in the form of rectal paracetamol (80-120mg) if pain score (Children's Hospital of Eastern Ontario Pain Scale CHEOPS was > 8 to be repeated every 6 hours if needed not to exceed 5 doses / 24 hr. Statistical analysis: SPSS(Statistical Package for Social Sciences) version 20.0 will be used for data entry and data management. Mean ± standard deviation will describe quantitative variables and proportions for qualitative variables. ANOVA with mixed model will be used to show time effect (e.g change of pain score over time post-operatively) and to show group effect, (compare rate of change among 3 study groups). P value will be set significant at 0.05 level and always 2 tailed. Sample size (number of participants included) This study hypothesized that at least 2 of the 3 study groups are significantly different regarding pain score after 6 hours post-operatively.With a type I error of 0.05, power of a test of 0.90 and a difference to be detected in pain score of 1.3 with background standard deviation of 0.9 (based on results from a study by H.-S. Na, J.-H. Lee, J.-Y. Hwang, J.-H. Ryu, S.-H. Han, Y.-T. Jeon and S.-H. Do.Effects of magnesium sulphate on intraoperative neuromuscular blocking agent requirements and postoperative analgesia in children with cerebral palsy.British Journal of Anaesthesia 104 (3): 34450(2010)doi:10.1093/bja/aep379& Gamal T. Yousef, Tamer H. Ibrahim, Ahmed Khder, et al. Enhancement of ropivacaine caudal analgesia using dexamethasone or magnesium in children undergoing inguinal hernia repair. Anesth Essays Res. 2014 Jan-Apr; 8(1): 13-19. doi: 10.4103/0259-1162.128895 , which showed a mean score of 2.4±0.9 in caudal group with IV magnesium versus 3.7±0.9 in control group), at least 16 patients per group is needed. To warrant normal distribution of study variables a total of 90 patients will be recruited in this study who will be randomized into 30 patient per group .

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Pain, Postoperative
    Keywords
    postoperative pain , pediatrics , magnesium sulfate

    7. Study Design

    Primary Purpose
    Supportive Care
    Study Phase
    Phase 4
    Interventional Study Model
    Parallel Assignment
    Masking
    ParticipantCare ProviderInvestigator
    Allocation
    Randomized
    Enrollment
    90 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Intravenous magnesium group (Group IV)
    Arm Type
    Experimental
    Arm Description
    Group IV (n=30) will receive intravenous (IV) 20 ml magnesium SO4 (50 mg/ kg 10% MgSO4(magnesium sulphate) diluted in normal saline to a total volume of 20 ml(milliliter) ) and caudal anaesthesia using (bupivacaine 0.25% diluted in normal saline with total volume of 1 mL/kg) .
    Arm Title
    Caudal magnesium group (Group CA)
    Arm Type
    Active Comparator
    Arm Description
    Group CA (n=30) will receive IV 20 ml normal saline and caudal anaesthesia using (bupivacaine 0.25% and 50 mg Magnesium SO4 diluted in normal saline with total volume of 1mL/kg).
    Arm Title
    Placebo group (Group P)
    Arm Type
    Placebo Comparator
    Arm Description
    Group P (n=30) ) will receive IV 20 ml normal saline and caudal anaesthesia using (bupivacaine 0.25% diluted in normal saline with total volume of 1 mL/kg).
    Intervention Type
    Drug
    Intervention Name(s)
    Magnesium SO4
    Other Intervention Name(s)
    Caudal anaesthesia
    Intervention Description
    The intravenous solutions (magnesium 10% for group IV or saline 0.9% for group CA and P) will be started then caudal block will be performed by the same anesthetist. Under complete aseptic conditions a caudal puncture with 5 cm short beveled 22 G caudal needle will be used in the lateral decubitus position. After identifying the space using the loss of resistance technique with saline, the study solutions will be injected slowly with repetitive intermittent aspiration.
    Primary Outcome Measure Information:
    Title
    The analgesic effect of intravenous magnesium in children undergoing lower abdominal surgeries
    Description
    Post operative pain score will be assessed using children's Hospital of Eastern Ontario Pain scale which is based on 6 criteria: Crying Facial expression Child verbal expression Torso (body position) Touching or grabbing at wound Legs position Criterion 1 is given a score of 1-3, criterion 2 and 3 are given a score of 0-2 while criterion 4, 5 and 6 are given a score of 1-2; making the worst possible score 13 while the least possible score is 4. A total score ≤ than 8 indicate adequate analgesia.
    Time Frame
    12 hours
    Secondary Outcome Measure Information:
    Title
    Time to first rescue analgesia
    Description
    Post operative first rescue analgesia time
    Time Frame
    12 hours
    Title
    Post operative sedation score
    Description
    Sedation will be monitored after PACU arrival using Ramsay score : 1=fully awake , 2=drowsy but awakens spontaneously , 3=asleep but arouses and responds appropriately to simple verbal commands , 4=asleep,unresponsive to commands,but arouses to shoulder tap or loud verbal stimulus , 5=asleep and only responds to firm
    Time Frame
    30 minutes

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    1 Year
    Maximum Age & Unit of Time
    7 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: age between 1 and 7 years, ASA(American Society of Anesthesiologists) physical status class |- || , patients scheduled for lower abdominal surgeries. Exclusion Criteria: patients with psychiatric disorders , children with cardiovascular,respiratory ,hepatic or renal dysfunction , known contraindications to regional anesthesia, ASA class |||- |V, hypersensitivity to magnesium or regular analgesic drugs.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Magda S Rezk
    Phone
    +20127812221
    Email
    Gloria_gloria4@hotmail.com
    First Name & Middle Initial & Last Name or Official Title & Degree
    Magda Elsharbatly
    Phone
    +201278122220
    Email
    Magdasaleh55@gmail.com
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Manal M El gohary
    Organizational Affiliation
    Professor
    Official's Role
    Principal Investigator
    First Name & Middle Initial & Last Name & Degree
    Amina A Ela
    Organizational Affiliation
    Assistant professor
    Official's Role
    Study Director
    First Name & Middle Initial & Last Name & Degree
    Heba M Nassar
    Organizational Affiliation
    Assistant professor
    Official's Role
    Study Chair

    12. IPD Sharing Statement

    Learn more about this trial

    Magnesium Sulfate as an Adjuvant to Caudal Bupivacaine in Lower Abdominal Surgeries in Paediatrics.

    We'll reach out to this number within 24 hrs